What monitoring parameters should be considered for a patient receiving treatment for delirium tremens?

Monitoring parameters for a patient receiving treatment for delirium tremens should include:

• Regular assessment of withdrawal symptoms using a validated tool such as the Clinical Institute Withdrawal Assessment – Alcohol, revised (CIWA-Ar) scale to quantify severity and guide treatment adjustments.
• Continuous clinical monitoring by healthcare professionals skilled in alcohol withdrawal management, ideally in a hospital setting where 24-hour assessment and monitoring are available.
• Observation for persistence or worsening of delirium tremens symptoms to consider escalation of treatment, including review and adjustment of withdrawal drug regimen.
• Monitoring for adverse effects of pharmacotherapy, particularly when using benzodiazepines (e.g., lorazepam) or haloperidol, including sedation level and respiratory status.
• Assessment for complications such as seizures, nutritional status, and signs of Wernicke's encephalopathy, with prophylactic thiamine administration as indicated.
• Vital signs monitoring including heart rate, blood pressure, respiratory rate, and temperature to detect autonomic instability common in delirium tremens.

These monitoring parameters ensure safe and effective management of delirium tremens and timely intervention if complications arise or treatment response is inadequate NICE CG100,NICE CG115.